C
CRINETICS PHARMACEUTICALS INC
NASDAQ: CRNX (Crinetics Pharmaceuticals, Inc.)
最近更新时间: 2小时之前51.88
0.56 (1.09%)
| 前收盘价格 | 51.32 |
| 收盘价格 | 51.00 |
| 成交量 | 679,988 |
| 平均成交量 (3个月) | 1,366,840 |
| 市值 | 5,318,314,496 |
| 价格/销量 (P/S) | 3.23 |
| 股市价格/股市净资产 (P/B) | 5.08 |
| 52周波幅 | |
| 利润日期 | 26 Feb 2026 |
| 营业利益率 (TTM) | -30,860.11% |
| 稀释每股收益 (EPS TTM) | -3.80 |
| 季度收入增长率 (YOY) | -43.60% |
| 总债务/股东权益 (D/E MRQ) | 4.05% |
| 流动比率 (MRQ) | 22.53 |
| 营业现金流 (OCF TTM) | -261.57 M |
| 杠杆自由现金流 (LFCF TTM) | -155.77 M |
| 资产报酬率 (ROA TTM) | -20.13% |
| 股东权益报酬率 (ROE TTM) | -30.84% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Crinetics Pharmaceuticals, Inc. | 看跌 | 看涨 |
AIStockmoo 评分
1.1
| 分析师共识 | 2.0 |
| 内部交易活动 | NA |
| 价格波动 | -0.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 0.5 |
| 平均 | 1.13 |
|
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 2.03% |
| 机构持股比例 | 112.39% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Price T Rowe Associates Inc /Md/ | 30 Sep 2025 | 5,306,248 |
| Ecor1 Capital, Llc | 30 Sep 2025 | 4,288,120 |
| Janus Henderson Group Plc | 30 Sep 2025 | 3,858,791 |
| Paradigm Biocapital Advisors Lp | 30 Sep 2025 | 2,550,774 |
| Jennison Associates Llc | 30 Sep 2025 | 2,044,734 |
| Point72 Asset Management, L.P. | 30 Sep 2025 | 2,003,333 |
| Siren, L.L.C. | 30 Sep 2025 | 1,688,611 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 105.00 (Citizens, 102.39%) | 购买 |
| 中 | 80.00 (54.20%) | |
| 低 | 67.00 (Goldman Sachs, 29.14%) | 购买 |
| 平均值 | 84.00 (61.91%) | |
| 总计 | 3 购买 | |
| 平均价格@调整类型 | 51.51 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Goldman Sachs | 12 Jan 2026 | 67.00 (29.14%) | 购买 | 55.35 |
| Citizens | 08 Jan 2026 | 105.00 (102.39%) | 购买 | 53.24 |
| 07 Nov 2025 | 108.00 (108.17%) | 购买 | 40.00 | |
| Morgan Stanley | 06 Jan 2026 | 80.00 (54.20%) | 购买 | 45.95 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合